Genetic Testing Prior Authorization Automation

The Unique Prior Authorization Landscape for Genetic Testing

Prior authorization for genetic testing is characterized by its specificity and frequent reliance on third-party benefit managers (RBMs). Tests like hereditary cancer panels, prenatal genetic testing, and pharmacogenomics often require detailed clinical documentation to justify medical necessity. Managing these requests manually involves navigating diverse payer portals and RBM platforms, leading to inconsistent workflows, documentation gaps, and prolonged decision times that impact patient care.

Klivira's End-to-End Automation for Genetic Testing PA

Klivira's platform automates the entire prior authorization lifecycle for genetic testing, from initial order to approval or denial management. Our system integrates directly with your EMR, leveraging CDS Hooks to detect PA requirements at the point of order for high-volume categories such as hereditary cancer panels, prenatal screenings, and pharmacogenomic tests. This proactive approach eliminates missed PAs and significantly reduces manual intervention.

Key Automation Steps for Genetic Testing Prior Authorizations

• **Automated Requirement Discovery**: Real-time identification of PA requirements for genetic tests via EMR integration (e.g., SMART App Launch on FHIR, CDS Hooks) and Da Vinci CRD-style coverage checks.
• **Intelligent Documentation Assembly**: Klivira pulls relevant FHIR resources (DocumentReference, DiagnosticReport, Condition, Observation) from the EMR to build comprehensive packets for specific genetic tests, aligning with payer and RBM criteria.
• **Payer-Specific Submission Routing**: Requests are routed through the optimal channel—Da Vinci PAS API, X12 278, payer portals (e.g., for eviCore or Avalon), or fax fallback—ensuring efficient delivery.
• **Real-Time Status Tracking**: Automated polling and webhook integration provide continuous updates on genetic testing PA status, surfacing changes directly to PA coordinators and ordering clinicians.
• **Approval Write-Back & Denial Management**: Authorization numbers are written back to the EMR, while denials are parsed (X12 CARC/RARC) and routed for auto-appeal, human review, or peer-to-peer scheduling, with timely-filing tracking.

Integrating Clinical Guidelines and Standards for Genetic Testing

Our automation incorporates clinical guidelines from bodies like NCCN (for hereditary cancer panels) and ASCO, ensuring that documentation aligns with evidence-based medical necessity criteria. Klivira adheres to industry standards including Da Vinci CRD, DTR, and PAS, as well as X12 278, to facilitate interoperability and streamline communication with payers and RBMs. This commitment to standards ensures compliance with evolving regulations like CMS-0057-F, particularly for impacted governmental plans.

Addressing Common Failure Modes in Genetic Testing PA

Manual genetic testing prior authorization workflows are prone to specific failure modes, including missed PA-required orders, documentation gaps, and lost-to-follow-up appeals. Klivira's automation directly addresses these challenges by providing immediate PA detection at order entry, minimizing callbacks for documentation, and maintaining robust appeal-status tracking with timely-filing window enforcement. This ensures that crucial genetic tests are not delayed or denied due to administrative oversight.